Clinical trial
Double-blind, Randomized, Placebo-controlled Study on Efficacy, Safety and Tolerability of Ancrod in Patients With Sudden Sensorineural Hearing Loss (SSHL)
NCT01621256 is registered in ClinicalTrials.gov with Nordmark Arzneimittel GmbH & Co. KG as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Double-blind, Randomized, Placebo-controlled Study on Efficacy, Safety and Tolerability of Ancrod in Patients With Sudden Sensorineural Hearing Loss (SSHL)
- Lead sponsor
- Nordmark Arzneimittel GmbH & Co. KG
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- May 31, 2013
- Completion date
- October 30, 2018
- Enrollment
- 31 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.